ARCHIVES

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

New Publications

May 4, 1990

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997

Most Comprehensive Centers Getting Core Grants Renewed

July 27, 1990

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997